Literature DB >> 18573928

Temporal and spatial distribution of clonal complexes of Streptococcus pneumoniae isolates resistant to multiple classes of antibiotics in Belgium, 1997 to 2004.

Heather Amrine-Madsen1, Johan Van Eldere, Robertino M Mera, Linda A Miller, James A Poupard, Elizabeth S Thomas, Wendy S Halsey, Julie A Becker, F Patrick O'Hara.   

Abstract

We performed multilocus sequence typing on 203 invasive disease isolates of Streptococcus pneumoniae to assess the clonal compositions of isolates from two provinces in Belgium and to determine the relationship between clones and antibiotic nonsusceptibility, particularly nonsusceptibility to two or more classes of antibiotics. The frequency of multiclass nonsusceptibility (MCNS) was higher in the province of West Flanders (38%) than in Limburg (21%). This difference was largely attributable to five clonal complexes (CC156, CC81, CC143, CC193, and CC1848), which contained high proportions of isolates with MCNS (>47%) and which were circulating at higher frequencies in West Flanders. The S. pneumoniae population changed over time, as CC156 and CC81 declined in frequency from 1997 to 1999 to 2001 to 2004. Over the same time period, the frequency of pneumococcal conjugate vaccine 7 (PCV7) serotypes dropped from 69% to 41%. In contrast, the nonvaccine serotype 19A increased in frequency from 2.1% to 6.6%. None of these changes can be attributed to PCV7 vaccine, as it was not in use in Belgium during the time period studied. There was evidence that MCNS clones flowed from West Flanders to Limburg.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573928      PMCID: PMC2533454          DOI: 10.1128/AAC.00358-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Association between antibiotic sales and public campaigns for their appropriate use.

Authors:  Isabelle Bauraind; José-Maria Lopez-Lozano; Arielle Beyaert; Jean-Louis Marchal; Bruno Seys; Fernande Yane; Erik Hendrickx; Herman Goossens; Paul M Tulkens; Ludo Verbist
Journal:  JAMA       Date:  2004-11-24       Impact factor: 56.272

Review 2.  Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment.

Authors:  D M Musher
Journal:  Clin Infect Dis       Date:  1992-04       Impact factor: 9.079

3.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

4.  Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

Authors:  Carrie L Byington; Matthew H Samore; Gregory J Stoddard; Steve Barlow; Judy Daly; Kent Korgenski; Sean Firth; David Glover; Jasmin Jensen; Edward O Mason; Cheryl K Shutt; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2005-05-26       Impact factor: 9.079

Review 5.  Epidemiological differences among pneumococcal serotypes.

Authors:  William P Hausdorff; Daniel R Feikin; Keith P Klugman
Journal:  Lancet Infect Dis       Date:  2005-02       Impact factor: 25.071

6.  Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.

Authors:  Johan Flamaing; Jan Verhaegen; Jos Vandeven; Nadine Verbiest; Willy E Peetermans
Journal:  J Antimicrob Chemother       Date:  2007-11-13       Impact factor: 5.790

7.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

8.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.

Authors:  Mark C Enright; Brian G Spratt
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

9.  Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002.

Authors:  Bernard Beall; M Catherine McEllistrem; Robert E Gertz; Stephanie Wedel; David J Boxrud; Antonio L Gonzalez; Marie-Jo Medina; Rekha Pai; Terry A Thompson; Lee H Harrison; Lesley McGee; Cynthia G Whitney
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Otitis media complications and treatment failures: implications of pneumococcal resistance.

Authors:  M D Poole
Journal:  Pediatr Infect Dis J       Date:  1995-04       Impact factor: 2.129

View more
  3 in total

1.  Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany.

Authors:  Stephanie Perniciaro; Matthias Imöhl; Christina Fitzner; Mark van der Linden
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

2.  Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae.

Authors:  Dylan R Pillai; Dea Shahinas; Alla Buzina; Remy A Pollock; Rachel Lau; Krishna Khairnar; Andrew Wong; David J Farrell; Karen Green; Allison McGeer; Donald E Low
Journal:  BMC Genomics       Date:  2009-12-30       Impact factor: 3.969

3.  Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children.

Authors:  Mark van der Linden; Ralf René Reinert; Winfried V Kern; Matthias Imöhl
Journal:  BMC Infect Dis       Date:  2013-02-05       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.